Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Collins

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Journal of Virology|August 1, 1997
The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L proteinK Juhasz, S S Whitehead, P T Bui, et al.
Virology|September 1, 1991
Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitopeA Martin-Gallardo, K A Fien, B T Hu, et al.
Vaccine|December 1, 1988
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virusR A Olmsted, R M Buller, P L Collins, et al.
Journal of Virology|January 9, 1999
Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccineM H Skiadopoulos, S Surman, J M Tatem, et al.
Vaccine|January 1, 1992
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSVM Connors, P L Collins, C Y Firestone, et al.
Journal of Neuroimmunology|April 30, 2025
Corrigendum to "Novel model of multiple sclerosis induced by EBV-like virus generate a unique B cell population" [Journal of Neuroimmunology volume 394 (2024) 578408]J L Deffenbaugh, K-J Jung, S P Murphy, et al.
Journal of Virology|September 12, 2000
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primatesA C Schmidt, J M McAuliffe, A Huang, et al.
Vaccine|April 1, 1988
Live viral vaccines for respiratory and enteric tract diseasesR M Chanock, B R Murphy, P L Collins, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Virus Research|August 1, 1988
Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial virusesB R Murphy, G A Prince, P L Collins, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Journal of Virology|August 1, 1997
The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L proteinK Juhasz, S S Whitehead, P T Bui, et al.
Virology|September 1, 1991
Expression of the F glycoprotein gene from human respiratory syncytial virus in Escherichia coli: mapping of a fusion inhibiting epitopeA Martin-Gallardo, K A Fien, B T Hu, et al.
Vaccine|December 1, 1988
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virusR A Olmsted, R M Buller, P L Collins, et al.
Journal of Virology|January 9, 1999
Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccineM H Skiadopoulos, S Surman, J M Tatem, et al.
Vaccine|January 1, 1992
Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSVM Connors, P L Collins, C Y Firestone, et al.
Journal of Neuroimmunology|April 30, 2025
Corrigendum to "Novel model of multiple sclerosis induced by EBV-like virus generate a unique B cell population" [Journal of Neuroimmunology volume 394 (2024) 578408]J L Deffenbaugh, K-J Jung, S P Murphy, et al.
Journal of Virology|September 12, 2000
Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primatesA C Schmidt, J M McAuliffe, A Huang, et al.
Vaccine|April 1, 1988
Live viral vaccines for respiratory and enteric tract diseasesR M Chanock, B R Murphy, P L Collins, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Virus Research|August 1, 1988
Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial virusesB R Murphy, G A Prince, P L Collins, et al.
Pageof 16